Briumvi 150 mg concentrate for solution for infusion | medicines.ie

Company: Neuraxpharm Pharmaceuticals, S.L.
Active Ingredient: ublituximab
Strength: ublituximab: 150 mg
Dosage Form: Concentrate for solution for infusion
Legal Category: B - prescription, may be renewed
Last Updated: 25/09/2026

Loading the document

Neuraxpharm Pharmaceuticals, S.L.